Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $922,698 | 3 | 72.4% |
| Consulting Fee | $346,618 | 31 | 27.2% |
| Travel and Lodging | $4,199 | 9 | 0.3% |
| Food and Beverage | $501.94 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1.2M | 41 | $0 (2024) |
| AYTU BioPharma, Inc. | $60,000 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $322,704 | 1 | GlaxoSmithKline, LLC. ($322,704) |
| 2023 | $320,297 | 1 | GlaxoSmithKline, LLC. ($320,297) |
| 2022 | $339,696 | 7 | GlaxoSmithKline, LLC. ($279,696) |
| 2021 | $125,000 | 12 | GlaxoSmithKline, LLC. ($125,000) |
| 2020 | $22,491 | 4 | GlaxoSmithKline, LLC. ($22,491) |
| 2019 | $18,753 | 5 | GlaxoSmithKline, LLC. ($18,753) |
| 2018 | $42,644 | 9 | GlaxoSmithKline, LLC. ($42,644) |
| 2017 | $82,431 | 8 | GlaxoSmithKline, LLC. ($82,431) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $322,704.43 | General |
| 12/31/2023 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $320,297.33 | General |
| 12/31/2022 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $279,695.75 | General |
| 12/01/2022 | AYTU BioPharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| 11/01/2022 | AYTU BioPharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| 10/01/2022 | AYTU BioPharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| 09/01/2022 | AYTU BioPharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| 08/01/2022 | AYTU BioPharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| 07/01/2022 | AYTU BioPharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| 12/28/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $9,999.96 | General |
| 12/28/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $9,999.96 | General |
| 12/21/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $9,166.63 | General |
| 11/03/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $9,166.63 | General |
| 11/03/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $7,499.97 | General |
| 09/22/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $6,666.64 | General |
| 08/18/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $11,666.62 | General |
| 07/14/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $12,499.95 | General |
| 07/08/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $10,833.29 | General |
| 04/22/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $11,666.62 | General |
| 04/07/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $14,166.61 | General |
| 03/10/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $11,666.62 | General |
| 12/21/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $14,994.00 | General |
| 12/21/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,332.00 | General |
| 12/21/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,499.00 | General |
| 12/21/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,666.00 | General |
About Dr. Harry Dietz, M.D
Dr. Harry Dietz, M.D is a Pediatrics healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114954906.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harry Dietz, M.D has received a total of $1.3M in payments from pharmaceutical and medical device companies, with $322,704 received in 2024. These payments were reported across 47 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($922,698).
Practice Information
- Specialty Pediatrics
- Other Specialties Clinical Genetics (M.D.)
- Location Baltimore, MD
- Active Since 06/27/2006
- Last Updated 12/10/2016
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1114954906
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Baltimore
Kenneth Cooke, Md, MD
Pediatrics — Payments: $397,951
Julie Hoover-Fong, M.d, M.D
Pediatrics — Payments: $209,959
Carmelo Cuffari, M.d, M.D
Pediatrics — Payments: $105,979
Dr. M. Elizabeth Younger, Cpnp, CPNP
Pediatrics — Payments: $101,884
Dr. Errol Fields, Md, Phd, Mph, MD, PHD, MPH
Pediatrics — Payments: $45,921
John Thomson
Pediatrics — Payments: $32,865